DrugPatentWatch Database Preview
Certolizumab pegol - Biologic Drug Details
Summary for certolizumab pegol
| Tradenames: | 1 |
| Patents: | 71 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for certolizumab pegol |
Recent Clinical Trials for certolizumab pegol
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| University of California, San Francisco | Phase 1 |
| Centre Hospitalier Universitaire de Saint Etienne | Phase 4 |
| UCB Biopharma S.P.R.L. | Phase 3 |
Pharmacology for certolizumab pegol
| Mechanism of Action | Tumor Necrosis Factor Receptor Blocking Activity |
Patent Text Search: US Patents for certolizumab pegol
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ucb Inc | CIMZIA | certolizumab pegol | INJECTABLE; INJECTION | 125160 | 001 | 2008-04-22 | Start Trial | Medarex, Inc. (Princeton, NJ) | 2025-11-08 | RX | search | |
| Ucb Inc | CIMZIA | certolizumab pegol | INJECTABLE; INJECTION | 125160 | 001 | 2008-04-22 | Start Trial | Tobinick; Edward Lewis (Los Angeles, CA) | 2019-02-24 | RX | search | |
| Ucb Inc | CIMZIA | certolizumab pegol | INJECTABLE; INJECTION | 125160 | 001 | 2008-04-22 | Start Trial | Stowers Institute for Medical Research (Kansas City, MO) | 2026-04-03 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for certolizumab pegol
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2013523098 | Start Trial |
| Hong Kong | 1220215 | Start Trial |
| Japan | 2016523981 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
